The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Considering the potential for an increase in chronic pain after the COVID-19 pandemic
Open accessAbstract
1. Introduction The COVID-19 pandemic has impacted the lives and health of persons worldwide, with potential for further effects in the future. The experience of living within this pandemic has disrupted daily life across all sectors, including those living with chronic pain (CP), those infected with the coronavirus Severe Acute Respiratory Syndrome (SARS)-CoV2, healthcare providers and essential workers, as well as those who remained physically healthy. The toll of this pandemic extends beyond physical illness, with important psychosocial stressors that include prolonged periods of limited interpersonal contact, isolation, fear of illness, future uncertainty, and financial strain. Uncertainty is fuelled by the constant media coverage, often with conflicting information, differing recommendations by public health authorities in different jurisdictions, and the unknown duration and likelihood of resurgence of this pandemic. In this context, we will examine the potential health consequences of COVID-19 germane to CP, which might be nociplastic, neuropathic, or nociceptive. Specific possibilities might include: (1) CP as part of a postviral syndrome or the result of viral-associated organ damage; (2) worsening of CP due to exacerbation of preexisting pain physical or mental complaints; and (3) CP newly triggered in individuals not infected with COVID by exacerbation of risk factors (poor sleep, inactivity, fear, anxiety, and depression). Chronic pain must be considered in the context of the biopsychosocial model, which views symptoms as the result of a complex and dynamic interaction between biological, psychological, and social factors.36,39 Underlying predisposing mechanisms include genetic factors, previous pain experience, and traumatic events that could be physical or emotional.2 Chronic pain conditions can be triggered by psychosocial stressors or organ-specific biological factors, which may preferentially occur in individuals with a fragile stress response system.8,10,24,40,47 The COVID-19 pandemic has many characteristics that could potentially increase the prevalence of CP, especially with stressors extending over many months. The worldwide pain community is invited to consider the possible downstream consequences of COVID-19, not only for patients surviving infection, but also for the wider community that has experienced psychological, social, and economic effects. Although we address these issues from the perspective of physicians practicing in developed countries, many of the consequences discussed will be particularly relevant for people in other countries, with a call for colleagues in Asia, Africa, and South America to enter into this dialogue. 2. Infections as a trigger for chronic pain Acute viral illnesses often present with myalgia and fatigue, as well as organ-specific symptoms, as seen with influenza, and noted in the H1N1 pandemics of 1918 and 2009, and coronavirus infection during the SARS epidemic.4,17 Outcomes related to these infections are almost always focused on the immediate response to the acute illness, with little attention to long-term outcomes. In a small study of 22 subjects (21 of whom were healthcare workers) infected during the SARS epidemic, a chronic post-SARS syndrome consisting of fatigue, diffuse myalgia, depression, and nonrestorative sleep persisted for almost 2 years.27 Similarly, some patients with chronic widespread pain report onset of symptoms after a perceived viral illness. Although some infections cause specific postinfectious syndromes, there is also a common stereotypical response to any type of infection that is often observed. For example, up to 12% of patients infected with 3 different pathogens, ie, Ross River virus (the cause of epidemic polyarthritis), Coxiella burnetii (cause of Q fever), and Epstein–Barr virus, experienced a postviral syndrome of pain, fatigue, and memory difficulties for up to 12 months after infection.15 Although these infections have markedly disparate acute presentations, a stereotypical chronic syndrome occurred at remarkably similar rates and was not predicted by demographic, psychological/psychiatric measures, or microbiological factors.15 The presence and severity of somatic symptoms during acute infection was closely correlated with the subsequent development of chronic fatigue and pain. Chronic regional pain and other somatic symptoms can follow other types of acute infection. In a meta-analysis, Halvorson et al. noted that approximately 10% of individuals will develop postinfectious irritable bowel syndrome after an episode of acute viral or bacterial gastroenteritis, with premorbid psychological problems and/or psychosocial stressors recognized as risk factors.7,13 On a similar note, an episode of acute urinary tract infection is evident in a substantial proportion of women who develop interstitial cystitis/painful bladder syndrome.43 Collectively, these findings imply that various acute infections are capable of trigg
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Estimates of the severity of coronavirus disease 2019: a model-based analysis
Verity, R., Okell, L. C., Dorigatti, I., Winskill, P., Whittaker, C., Imai, N., Cuomo-Dannenburg, G., Thompson, H., Walker, P. G. T., Fu, H., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30243-7 · Cited by 3,660
COVID-19 and mental health: A review of the existing literature
Rajkumar, R. P. (2020) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2020.102066 · Cited by 3,574 · cited 1×
“preliminary evidence that anxiety and depression (16%-28%), self-reported stress (8%), and sleep disturbances are common reactions to this pandemic.(31) During the SARS outbreak in 2003, an historically high suicide rate of 18.”
BackgroundEULAR revised recommendations for the management of fibromyalgia
Macfarlane, G. J., Kronisch, C., Dean, L. E., Atzeni, F., Häuser, W., Fluß, E., Choy, E., Kosek, E., Amris, K., Branco, J., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209724 · Cited by 1,566
Self-citationWhy stress is bad for your brain
Sapolsky, R. M. (1996) · Science · doi:10.1126/science.273.5276.749 · Cited by 1,306 · cited 1×
“Exposure to a multitude of stressors simultaneously, or over time, may also pose significant risk for later somatic and/or psychological sequelae.(14,33) For example, in military personnel, multiple deployments significantly increase the risk for PTSD and other psychiatric conditions, which in turn are highly copreval…”
BackgroundStress and psychological distress among SARS survivors 1 year after the outbreak
Lee, A. M., Wong, J. G., McAlonan, G. M., Cheung, V., Cheung, C., Sham, P. C., Chu, C.-M., Wong, P.-C., Tsang, K. W., & Chua, S. E. (2007) · The Canadian Journal of Psychiatry · doi:10.1177/070674370705200405 · Cited by 1,195 · cited 1×
“Between 41% and 65% of SARS survivors have experienced persistent psychological symptoms.(20,23) Between 25% and 44%”
BackgroundLong-term psychiatric morbidities among SARS survivors
Mak, I. W. C., Chu, C. M., Pan, P. C., Yiu, M. G. C., & Chan, V. L. (2009) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2009.03.001 · Cited by 1,018 · cited 2×
“of Hong Kong residents who were infected with SARS and survived were diagnosed with posttraumatic stress disorder (PTSD), and 15% experienced depression for at least 30 months after the illness.(16,22) Posttraumatic stress disorder also occurred in 40.”
BackgroundHickie, I., Davenport, T., Wakefield, D., Vollmer-Conna, U., Cameron, B., Vernon, S. D., Reeves, W. C., & Lloyd, A. (2006) · BMJ · doi:10.1136/bmj.38933.585764.ae · Cited by 822
Heim, C., Newport, D. J., Bonsall, R., Miller, A. H., & Nemeroff, C. B. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.4.575 · Cited by 746
Schelling, G., Stoll, C., Haller, M., Briegel, J., Manert, W., Hummel, T., Lenhart, A., Heyduck, M., Polasek, J., Meier, M., et al. (1998) · Critical Care Medicine · doi:10.1097/00003246-199804000-00011 · Cited by 606
Moldofsky, H., & Patcai, J. (2011) · BMC Neurology · doi:10.1186/1471-2377-11-37 · Cited by 604
Research works printed but not linked: 3
- Barski, 2020, High prevalence of fibromyalgia syndrome among Israeli nurses, Clin Exp Rheumatol, 38, 25
- Kosciuczuk, 2020, Opioid-induced immunosuppression and carcinogenesis promotion theories create the newest trend in acute and chronic pain pharmacotherapy, Clinics (Sao Paulo, Brazil), 75, e1554, 10.6061/clinics/2020/e1554 · doi:10.6061/clinics/2020/e1554
- Uceyler, 2017, Etiology and pathophysiology of fibromyalgia syndrome: updated guidelines 2017, overview of systematic review articles and overview of studies on small fiber neuropathy in FMS subgroups, Schmerz (Berlin, Germany), 31, 239
Cited by
Systemic and organ-specific immune-related manifestations of COVID-19
Ramos-Casals, M., Brito-Zerón, P., & Mariette, X. (2021) · Nature Reviews Rheumatology · doi:10.1038/s41584-021-00608-z · Cited by 309
Lacasse, A., Pagé, M. G., Dassieu, L., Sourial, N., Janelle-Montcalm, A., Dorais, M., Nguena Nguefack, H. L., Godbout-Parent, M., Hudspith, M., Moor, G., et al. (2021) · PAIN Reports · doi:10.1097/pr9.0000000000000891 · Cited by 62
Sanabria-Mazo, J. P., Colomer-Carbonell, A., Borràs, X., Castaño-Asins, J. R., McCracken, L. M., Montero-Marin, J., Pérez-Aranda, A., Edo, S., Sanz, A., Feliu-Soler, A., et al. (2023) · The Journal of Pain · doi:10.1016/j.jpain.2023.04.008 · Cited by 40
Could the fibromyalgia syndrome be triggered or enhanced by COVID-19?
Fialho, M. F. P., Brum, E. S., & Oliveira, S. M. (2023) · Inflammopharmacology · doi:10.1007/s10787-023-01160-w · Cited by 33
Bartels, S. L., Johnsson, S. I., Boersma, K., Flink, I., McCracken, L. M., Petersson, S., Christie, H. L., Feldman, I., Simons, L. E., Onghena, P., et al. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-059152 · Cited by 23
Metadata
- Authors
- Clauw, D. J., Häuser, W., Cohen, S. P., & Fitzcharles, M.-A.
- Venue
- Pain
- Published
- 2020-06-03
- Volume
- 161
- Issue
- 8
- Pages
- 1694-1697
- ISSN
- 0304-3959 (ISSN-L)
- 1872-6623
- OpenAlex
- W3033350628
- Cited by
- 318
- References
- 43
- FWCI
- 23.28
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Considering the potential for an increase in chronic pain after the COVID-19 pandemic. https://app.cochat.ai/papers/10.1097/j.pain.0000000000001950
- The paper
- Clauw, D. J., Häuser, W., Cohen, S. P., & Fitzcharles, M.-A. (2020). Considering the potential for an increase in chronic pain after the COVID-19 pandemic. Pain. https://doi.org/10.1097/j.pain.0000000000001950
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.